Targeting the RNA demethylase FTO for cancer therapy-Reference-Cited by-同舟云学术

Targeting the RNA demethylase FTO for cancer therapy

Published:2021 Issue:5 Volume:2 Page:1352-1369
ISSN:2633-0679
Container-title:RSC Chemical Biology
language:en
Short-container-title:RSC Chem. Biol.

Author:

Zhou Lin-Lin¹²^ORCID,Xu Hongjiao¹²^ORCID,Huang Yue¹³^ORCID,Yang Cai-Guang¹²³^ORCID

Affiliation:

1. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2. University of the Chinese Academy of Sciences, Beijing 100049, China

3. School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China

Abstract

Chemical modulation of the RNA m6A demethylase FTO for cancer therapy.

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2021/CB/D1CB00075F

Reference112 articles.

1. Covalent modifications of histones during development and disease pathogenesis

2. Advances in epigenetics link genetics to the environment and disease

3. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer

4. Existence of methylated messenger RNA in mouse L cells

5. Identification of Methylated Nucleosides in Messenger RNA from Novikoff Hepatoma Cells

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bioorthogonal Post-modification of N ⁶ -Isopentenyl Adenosine i ⁶ A RNA in Live Cells;CCS Chemistry;2024-09

2. Epitranscriptome: A Novel Regulatory Layer during Atherosclerosis Progression;Current Medicinal Chemistry;2024-08-30

3. Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors;Future Medicinal Chemistry;2024-08-05

4. Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents;European Journal of Medicinal Chemistry;2024-08

5. Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy;Acta Pharmaceutica Sinica B;2024-07